SCM
Sio Capital Management Portfolio holdings
AUM
$249M
1-Year Return
117.71%
This Quarter Return
-12.98%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$280M
AUM Growth
-$49.2M
(-15%)
Cap. Flow
-$30M
Cap. Flow
% of AUM
-10.71%
Top 10 Holdings %
Top 10 Hldgs %
51.06%
Holding
103
New
34
Increased
13
Reduced
15
Closed
27
Top Buys
| 1 |
Amgen
AMGN
|
$21.5M |
| 2 |
Biogen
BIIB
|
$13.3M |
| 3 |
Boston Scientific
BSX
|
$12.9M |
| 4 |
Envista
NVST
|
$12.8M |
| 5 |
SPDR Gold Trust
GLD
|
$9.58M |
Top Sells
| 1 |
Medtronic
MDT
|
$16.7M |
| 2 |
Pfizer
PFE
|
$14.9M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$14.8M |
| 4 |
Gilead Sciences
GILD
|
$12.1M |
| 5 |
GSK
GSK
|
$9.62M |
Sector Composition
| 1 | Healthcare | 89.79% |
| 2 | Technology | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Viking Therapeutics
VKTX
$2.95B
| $3.52M | 1.18% |
752,241
+20,788
| +3% | +$97.3K |
|
|
SYNH
27
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $3.04M | 1.02% |
77,131
+23,834
| +45% | +$940K |
|
|
SYRS
28
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $2.78M | 0.93% |
46,853
+2,000
| +4% | +$119K |
|
29
Esperion Therapeutics
ESPR
$504M
| $2.54M | 0.85% |
80,600
+23,942
| +42% | +$755K |
|
30
Alkermes
ALKS
$4.79B
| $2.45M | 0.82% |
+170,042
| New | +$2.45M |
|
|
LSACU
31
DELISTED
LifeSci Acquisition Corp. Unit 1 COM & 1 WT
LSACU
| $2.1M | 0.7% |
+210,000
| New | +$2.1M |
|
32
Pediatrix Medical
MD
$1.47B
| $2.06M | 0.69% |
+176,690
| New | +$2.06M |
|
|
RVLP
33
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $1.83M | 0.61% |
+575,000
| New | +$1.83M |
|
34
Larimar Therapeutics
LRMR
$330M
| $1.8M | 0.6% |
194,347
+4,083
| +2% | +$37.7K |
|
35
Immunovant
IMVT
$2.87B
| $1.78M | 0.6% |
114,133
-501,267
| -81% | -$7.8M |
|
36
Leap Therapeutics
LPTX
$12M
| $1.74M | 0.58% |
109,954
+62,332
| +131% | +$985K |
|
|
TRIL
37
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.69M | 0.57% |
417,577
-2,333,609
| -85% | -$9.43M |
|
|
AFMD
38
DELISTED
Affimed
AFMD
| $1.61M | 0.54% |
101,820
| – | – |
|
39
Ascendis Pharma
ASND
$12.2B
| $1.56M | 0.52% |
+13,889
| New | +$1.56M |
|
40
HealthEquity
HQY
$8.44B
| $1.55M | 0.52% |
+30,700
| New | +$1.55M |
|
41
Medpace
MEDP
$13.4B
| $1.53M | 0.51% |
20,858
-5,743
| -22% | -$422K |
|
|
KDMN
42
DELISTED
Kadmon Holdings, Inc.
KDMN
| $1.41M | 0.47% |
+337,500
| New | +$1.41M |
|
43
Cencora
COR
$56.8B
| $1.41M | 0.47% |
15,928
-95,321
| -86% | -$8.44M |
|
|
ASLN
44
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
| $1.32M | 0.44% |
32,373
+6,924
| +27% | +$283K |
|
45
Verastem
VSTM
$636M
| $1.3M | 0.44% |
+41,007
| New | +$1.3M |
|
46
Harrow
HROW
$1.37B
| $1.19M | 0.4% |
311,640
-33,300
| -10% | -$127K |
|
47
Neurogene
NGNE
$280M
| $1M | 0.34% |
4,409
| – | – |
|
48
Mersana Therapeutics
MRSN
$34.6M
| $969K | 0.32% |
6,650
| – | – |
|
49
Gyre Therapeutics
GYRE
$687M
| $956K | 0.32% |
29,162
+1,872
| +7% | +$61.4K |
|
|
NXGN
50
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $946K | 0.32% |
+90,657
| New | +$946K |
|